Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial - Concepedia

Concepedia

Publication | Closed Access

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

27

Citations

25

References

2019

Year

Andreas Hüttmann, Jan Rekowski, Stefan Müller, Bernd Hertenstein, Christiane Franzius, Rolf M. Mesters, Matthias Weckesser, Frank Kroschinsky, Jörg Kotzerke, Arnold Ganser,

Annals of Hematology

Lymphoid NeoplasiaMedicinePathologySix Versus EightOncologyRadiation Oncology

References

	Year	Citations

Page 1